J. Wolchko | executive |
Edward Dulac | executive |
Ashiq Mubarack | analyst |
Tyler Van Buren | analyst |
Daina Graybosch | analyst |
Kelsey Goodwin | analyst |
Matthew Biegler | analyst |
Peter Lawson | analyst |
Yanan Zhu | analyst |
Etzer Darout | analyst |
Bob Valamehr, Ph.D. | executive |
Mara Goldstein | analyst |
Welcome to the Fate Therapeutics Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] The call is being webcast live on the Investors section of Fate's website at fatetherapeutics.com.
As a reminder, today's call is being recorded. I would now like to introduce Scott Wolchko, President and CEO of Fate Therapeutics.
Thank you.